Fig. 1From: Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective studyFlow chart showing the study population. Four hundred and thirty-five patients were identified from the database of patients with localized and resected pancreatic cancer. Of the 223 with recurrent pancreatic ductal adenocarcinoma, 140 received systemic hemotherapy and 71 did notBack to article page